OCS-05 was well tolerated and improved vision and eye health in a Phase 2 trial in 33 people with optic neuritis due to MS or ...

Oculis Holding’s OCS-05 phase 2 ACUITY trial in acute optic neuritis meets primary safety endpoint and key secondary efficacy endpoints: Zug, Switzerland Tuesday, January 7, 202 ...

VMPL Bengaluru Karnataka [India] January 8 ZEISS a globally leading player in optics and optoelectronics conducted an eye checkup camp for drivers in partnership with Shell India This initiative was p ...

The multinational, multicenter, prospective RESTORE Study is the 5-year follow-up study of the phase 3 clinical RESCUE and ...

The rates at which ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thin in the eyes was ...

Glaucoma patients show slower visual response times, indicating impaired visual signal processing rather than motor or ...

SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.

1386 of these pupils were then interviewed and underwent a full eye examination by an eye team. RESULTS 10 pupils (0.7%) had bilateral poor eyesight (visual acuity worse than 6/12), and an additional ...

The phase 3 trial showed biosimilar CT-P42 (Celltrion) is therapeutically equivalent to reference aflibercept in improving ...

Ophthalmic Imaging Center, Cole Eye Institute/Cleveland Clinic ... There was no correlation between subfoveal choroidal thickness and visual acuity or retinal thickness in the RP patients when ...